The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study-Reference-Cited by-同舟云学术

The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study

Published:2023-02-10 Issue:3 Volume:12 Page:891-917
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Soriano Alex,Montravers Philippe,Bassetti Matteo,Klyasova Galina,Daikos George,Irani Paurus,Stone Gregory,Chambers Richard,Peeters Pascale,Shah Mitesh,Hulin Claire,Albuquerque Natalia,Basin Efim,Gaborit Benjamin,Kourbeti Irene,Menichetti Francesco,Perez-Rodriguez María Teresa,Pletz Mathias W.,Sanchez Marisa,Trompa Ivan,Verma Anita,de Figueiredo Maria Lavinea N.,Charbonneau Claudie

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-023-00762-9.pdf

Reference28 articles.

1. Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–41.

2. Bates DW, Larizgoitia I, Prasopa-Plaizier N, Jha AK. Global priorities for patient safety research. BMJ. 2009;338: b1775.

3. Zarb P, Coignard B, Griskeviciene J, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012. https://doi.org/10.2807/ese.17.46.20316-en.

4. World Health Organizations. Annual epidemiological report on communicable disease in Europe. 2008. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/0812_SUR_Annual_Epidemiological_Report_2008.pdf. Accessed 22 Feb 2018.

5. Annual epidemiological report Reporting on 2011 surveillance data and 2012 epidemic intelligence data. 2013. https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/annual-epidemiological-report-2013.pdf. Accessed 21 Oct 2021.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to ceftazidime–avibactam and other new β-lactams in Pseudomonas aeruginosa clinical isolates: a multi-center surveillance study;Microbiology Spectrum;2024-08-06

2. In vitro activity of ceftazidime-avibactam against gram-negative bacteria in patients with bacteremia and skin and soft-tissue infections in Colombia 2019–2021;Diagnostic Microbiology and Infectious Disease;2024-06

3. Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study;Open Forum Infectious Diseases;2024-05-08

4. Effectiveness of Ceftazidime-Avibactam in Gram-Negative Nosocomial Pneumonia: A Real-World Study in India;Cureus;2024-02-19

5. Carbapenem-Resistant Enterobacteriaceae in Urinary Tract Infections: From Biological Insights to Emerging Therapeutic Alternatives;Medicina;2024-01-26